Clinical Trial Update: Protego DF4 Post Approval Registry

View source ↗

Summary

Post-approval registry update for Protego DF4; the trial was terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia
• Implantable Defibrillator Recipient

Drugs mentioned

• Protego DF4

Snippet

Sponsor: Biotronik, Inc. | Conditions: Implantable Defibrillator User | Status: TERMINATED | Results posted: 2020-04-22